Publications
Original Article
Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant
Cancer Vaccines
2003
Authors:
McNeel DG, Knutson KL, Schiffman K, Davis D, Caron D and Disis ML
Journal:
Journal of Clinical Immunology
Volume:
23(1)
Page:
62-72
Pubmed:
Original Article
Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens
Cancer Vaccines
2003
Authors:
Disis ML, Shiota FM, McNeel DG, Knutson KL
Journal:
immunobiology
Volume:
207(3)
Page:
179-86
Pubmed:
Original Article
Delayed type hypersensitivity response to recall antigens does not accurately reflect immune competence in advanced stage breast cancer patients
General Immune Research
2002
Authors:
Schiffman K, Rinn K, Disis ML
Journal:
Breast Cancer Research and Treatment
Volume:
74(1)
Page:
17-23
Pubmed:
Original Article
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers
Cancer Vaccines
2002
Authors:
Disis ML, Rinn K, Knutson KL, Davis D, Caron D, dela Rosa C, Schiffman K
Journal:
Blood
Volume:
99(8)
Page:
2845-50
Pubmed:
Original Article
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patient
Cancer Vaccines
2002
Authors:
Knutson KL and Disis ML
Journal:
Human Immunology
Volume:
63(7)
Page:
547-57
Pubmed:
Original Article
Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines
Cancer Vaccines
2002
Authors:
Disis ML, Gooley TA, Rinn K, Davis D, Piepkorn M, Cheever MA, Knutson KL, Schiffman K
Journal:
Journal of Clinical Oncology
Volume:
20(11)
Page:
2624-32
Pubmed:
Original Article
Immunization of cancer patients with a HER-2/neu, HLA-A2 peptide, p369-377, results in short-lived peptide-specific immunity
Cancer Vaccines
2002
Authors:
Knutson KL, Schiffman K, Cheever MA, Disis ML
Journal:
Clinical Cancer Research
Volume:
8(5)
Page:
1014-8
Pubmed:
Original Article
Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer
T Cell Function & Therapy
2001
Authors:
McNeel DG, Nguyen LD, Ellis WJ, Higano CS, Lange PH, Disis ML
Journal:
Prostate
Volume:
47(3)
Page:
222-9
Pubmed:
Original Article
Issues on clinical applications of cancer vaccines
Cancer Vaccines
2001
Authors:
Disis ML and Schiffman K
Journal:
Journal of Immunotherapy
Volume:
24(2)
Page:
104-5
Pubmed:
Original Article
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
Cancer Vaccines
2001
Authors:
Knutson KL, Schiffman K, Disis ML
Journal:
The Journal of Clinical Investigation
Volume:
107(4)
Page:
477-84
Pubmed: